This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
  • Home
  • /
  • Drugs
  • /
  • A
  • /
  • Acyclovir
  • /
  • Acyclovir ACYCLOVIR SODIUM 1000 mg/1 Zydus Lifesciences Limited
FDA Drug information

Acyclovir

Read time: 1 mins
Marketing start date: 05 Nov 2024
...
 

Summary of product characteristics


Effective Time

20221017

Version

4

Spl Product Data Elements

acyclovir ACYCLOVIR ACYCLOVIR SODIUM ACYCLOVIR SODIUM HYDROXIDE WATER acyclovir ACYCLOVIR ACYCLOVIR SODIUM ACYCLOVIR SODIUM HYDROXIDE WATER

Application Number

ANDA206606

Brand Name

Acyclovir

Generic Name

ACYCLOVIR

Product Ndc

70771-1082

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL Acyclovir for Injection, USP 500 mg/vial - Vial Label NDC 70771-1081-1 Acyclovir for Injection, USP Equivalent to 500 mg/vial acyclovir For Intravenous Infusion Only Rx only zydus pharmaceuticals Acyclovir for Injection, USP 500 mg/vial - Carton Label NDC 70771-1081-6 Acyclovir for Injection, USP Equivalent to 500 mg/vial acyclovir For Intravenous Infusion Only 10 x 500 mg vials Rx only zydus pharmaceuticals Acyclovir for Injection, USP 1000 mg/vial - Vial Label NDC 70771-1082-1 Acyclovir for Injection, USP Equivalent to 1000 mg/vial acyclovir For Intravenous Infusion Only Rx only zydus pharmaceuticals Acyclovir for Injection, USP 1000 mg/vial - Carton Label NDC 70771-1082-6 Acyclovir for Injection, USP Equivalent to 1000 mg/vial acyclovir For Intravenous Infusion Only 10 x 1000 mg vials Rx only zydus pharmaceuticals Acyclovir sodium Injection, 500 mg/vial Acyclovir for Injection USP, 500 mg/Vial Acyclovir for Injection USP, 1000 mg/vial Vial Label Rx Only Acyclovir sodium Injection, 50 mg/mL Acyclovir for Injection USP, 1000 mg/vial

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.